Arjo Ab Stock Performance
| ARRJF Stock | USD 3.35 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Arjo AB are expected to decrease at a much lower rate. During the bear market, Arjo AB is likely to outperform the market. At this point, Arjo AB has a negative expected return of -0.0635%. Please make sure to confirm Arjo AB's coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to decide if Arjo AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Arjo AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking indicators, Arjo AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 972 M | |
| Total Cashflows From Investing Activities | -695 M | |
| Free Cash Flow | 974 M |
Arjo |
Arjo AB Relative Risk vs. Return Landscape
If you would invest 350.00 in Arjo AB on September 26, 2025 and sell it today you would lose (15.00) from holding Arjo AB or give up 4.29% of portfolio value over 90 days. Arjo AB is currently producing negative expected returns and takes up 0.8742% volatility of returns over 90 trading days. Put another way, 7% of traded pink sheets are less volatile than Arjo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Arjo AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arjo AB's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Arjo AB, and traders can use it to determine the average amount a Arjo AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0726
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARRJF |
Based on monthly moving average Arjo AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arjo AB by adding Arjo AB to a well-diversified portfolio.
Arjo AB Fundamentals Growth
Arjo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Arjo AB, and Arjo AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arjo Pink Sheet performance.
| Return On Equity | 0.0616 | |||
| Return On Asset | 0.0335 | |||
| Profit Margin | 0.04 % | |||
| Current Valuation | 1.13 B | |||
| Shares Outstanding | 272.37 M | |||
| Price To Earning | 71.78 X | |||
| Price To Book | 1.43 X | |||
| Price To Sales | 1.13 X | |||
| Revenue | 9.07 B | |||
| EBITDA | 2.03 B | |||
| Cash And Equivalents | 70.15 M | |||
| Cash Per Share | 0.26 X | |||
| Total Debt | 118 M | |||
| Debt To Equity | 0.94 % | |||
| Book Value Per Share | 2.23 X | |||
| Cash Flow From Operations | 1.73 B | |||
| Earnings Per Share | 0.19 X | |||
| Total Asset | 14.61 B | |||
About Arjo AB Performance
By analyzing Arjo AB's fundamental ratios, stakeholders can gain valuable insights into Arjo AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Arjo AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arjo AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Arjo AB develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. The company was founded in 1957 and is headquartered in Malm, Sweden. Arjo Ab operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 6500 people.Things to note about Arjo AB performance evaluation
Checking the ongoing alerts about Arjo AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Arjo AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arjo AB generated a negative expected return over the last 90 days | |
| About 21.0% of the company shares are held by company insiders |
- Analyzing Arjo AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arjo AB's stock is overvalued or undervalued compared to its peers.
- Examining Arjo AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arjo AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arjo AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arjo AB's pink sheet. These opinions can provide insight into Arjo AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Arjo Pink Sheet analysis
When running Arjo AB's price analysis, check to measure Arjo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arjo AB is operating at the current time. Most of Arjo AB's value examination focuses on studying past and present price action to predict the probability of Arjo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arjo AB's price. Additionally, you may evaluate how the addition of Arjo AB to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |